Airsonett
Not stated on page, SE · 3 known investors
Airsonett develops Temperature Laminar Airflow (TLA) medical devices for non-pharmacologic treatment of allergic asthma and eczema. The company's flagship Air4 device is a CE-marked class I medical device and FDA-cleared class II device intended for home use to reduce allergens and airborne irritants in patients' breathing zones.
Investors · 3
In the news
Frequently asked questions
- What does Airsonett do?
- Airsonett develops Temperature Laminar Airflow (TLA) medical devices for non-pharmacologic treatment of allergic asthma and eczema. The company's flagship Air4 device is a CE-marked class I medical device and FDA-cleared class II device intended for home use to reduce allergens and airborne irritants in patients' breathing zones.
- Who are Airsonett's investors?
- Airsonett's investors include Industrifonden, SEB Venture Capital, FSG.
- Where is Airsonett headquartered?
- Airsonett is headquartered in Not stated on page, SE.